Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peter J, Lin"'
Autor:
Anatoly Langer, MD, MSc, FRCP, Mary Tan, MSc, CCRP, Shaun G. Goodman, MD, MSc, FRCP, Jean Grégoire, MD, FRCP, Peter J. Lin, MD, CCFP, G. B. John Mancini, MD, FRCP, James A. Stone, MD, PhD, FRCP, Cheryll Wills, CCRP, Caroline Spindler, CCRP, Lawrence A. Leiter, MD, FRCP
Publikováno v:
CJC Open, Vol 2, Iss 2, Pp 49-54 (2020)
Background: Despite the widespread use of statins, approximately 40% to 50% of Canadian patients with known cardiovascular disease do not achieve the low-density lipoprotein cholesterol (LDL-C) goal. Guidelines Oriented Approach to Lipid lowering (GO
Externí odkaz:
https://doaj.org/article/172f99842e804604a2087b7706fdd64a
Autor:
Peter J. Lin, Eskil B. Kreiner, Robert Bauer, Vanita R. Aroda, Alun L. Davies, Richard E. Pratley, Stephen C. Bain
Publikováno v:
Diabetes. 70
As the first oral GLP-1 receptor agonist (GLP-1RA), oral semaglutide (sema) may facilitate increased access to the benefits of GLP-1RA therapy in broader care settings. Understanding the management of GLP-1RA therapy when intolerability occurs, inclu
Autor:
Jessica Lee Harding, Joseph A. Vassalotti, Jessie Pavlinac, Laura Sola, Borislava Mihaylova, Magdalena Madero, Xiaoqiang Ding, Vivekanand Jha, Vasantha Jotwani, Sophia Zoungas, Zanfina Ademi, Andrew S. Levey, Leah S. Karliner, Andrew E. Moran, Ian H. de Boer, Matthew R. Weir, Brenda R. Hemmelgarn, Jesse C. Seegmiller, L. Ebony Boulware, Joachim H. Ix, Ella Zomer, Wolfgang C. Winkelmayer, Radica Z. Alicic, Verónica Martínez, Georgi Abraham, James Tattersall, Adrian Liew, Neil R. Powe, Michel Jadoul, Raj Deo, Ron T. Gansevoort, Gregorio T. Obrador, Andre Pascal Kengne, Mai Nguyen, Donal O'Donoghue, Peter J. Lin, Guillermo Garcia-Garcia, Linda F. Fried, Joanna Q. Hudson, Michael Cheung, Maarten W. Taal, Rukshana Shroff, Andrea O.Y. Luk, Morgan E. Grams, Sri Lekha Tummalapalli, Michael G. Shlipak, Jenny I. Shen, Kevin J. Fowler, Meda E. Pavkov, Kunitoshi Iseki, Natalie Ebert, Navdeep Tangri
Publikováno v:
Kidney international, Vol. 99, p. 34-47 (2021)
Kidney International, 99(1), 34-47. ELSEVIER SCIENCE INC
Kidney international, Vol. 99, no.1, p. 34-47 (2021)
Kidney International, 99(1), 34-47. ELSEVIER SCIENCE INC
Kidney international, Vol. 99, no.1, p. 34-47 (2021)
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular and all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de5fe9137310aa28e49c898892bba1b
https://ora.ox.ac.uk/objects/uuid:03452f0a-1c0c-4a90-b172-b3481649ef2f
https://ora.ox.ac.uk/objects/uuid:03452f0a-1c0c-4a90-b172-b3481649ef2f
Autor:
Rasmus Sørrig, Morten Abildlund Nielsen, Klaus Kallenbach, Eduard Montanya, Cyrus Desouza, Peter J. Lin, Aslam Amod
Publikováno v:
Diabetes. 69
The global PIONEER program investigated the efficacy and safety of oral semaglutide, a glucagon-like peptide-1 receptor agonist. Patients with type 2 diabetes were randomized to once-daily oral semaglutide (3, 7 or 14 mg, or flexibly dosed [flex]), p
Autor:
Johannes Nolte, Francesc Xavier Cos, Pamela R. Kushner, Gary F. Deed, Stephen Brunton, Peter J. Lin, Naresh Kanumilli
Publikováno v:
Diabetes. 69
Background: Despite recent recommendations for the use of glucose-lowering therapies with additional cardiovascular (CV) and renal benefits, as demonstrated through CV outcomes trials (CVOTs), many patients (pts) with type 2 diabetes mellitus (T2D) m
Autor:
Peter J Lin
Publikováno v:
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 52
Autor:
Alexandra, Silberberg, Mary K, Tan, Andrew T, Yan, Paul, Angaran, Paul, Dorian, Claudia, Bucci, Jean C, Gregoire, Alan D, Bell, David J, Gladstone, Martin S, Green, Peter L, Gross, Allan, Skanes, Andrew M, Demchuk, Charles R, Kerr, L Brent, Mitchell, Jafna L, Cox, Mario, Talajic, Vidal, Essebag, Brett, Heilbron, Krishnan, Ramanathan, Carl, Fournier, Bruce H, Wheeler, Peter J, Lin, Murray, Berall, Anatoly, Langer, Lianne, Goldin, Shaun G, Goodman
Publikováno v:
The American journal of cardiology. 120(4)
Using data collected from 2 national atrial fibrillation (AF) primary care physician chart audits (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation [FREEDOM AF] and Co-ordinated National Network to Engage Physici
Autor:
Peter J. Lin
Publikováno v:
European Heart Journal Supplements. 7:E15-E20
For nearly 60 years, vitamin K antagonists (VKAs) such as warfarin have been the mainstay of oral anticoagulation in a range of thromboembolic disorders, ranging from stroke prevention in atrial fibrillation (AF) to the treatment and secondary preven
Autor:
Peter J Lin
Publikováno v:
Canadian Journal of Ophthalmology. 52:S11